PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-01-03

Date Title Company
03-Jan-2024 Best Dentists in Baltimore 2023 by TopRatedDentist.com AccessWire
03-Jan-2024 Pioneering initiative launched to increase the number of pharmacists in the South West University of Bath
03-Jan-2024 OncoZenge submits application for PRIME status in the EU OncoZenge
03-Jan-2024 AMLo Biosciences publish pivotal data for diagnostic biomarker technology AMBLor® in identifying melanomas at low risk of metastasis AMLo Biosciences
03-Jan-2024 iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference iTeos Therapeutics, Inc.
03-Jan-2024 PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference PureTech Health plc
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 Mundipharma announces European approval of REZZAYO® (rezafungin) for the treatment of Invasive Candidiasis in adults Mundipharma
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 NICE publishes positive final draft guidance for Sanofi’s innovative medicine Rezurock® (belumosudil) for patients with chronic graft-versus-host disease (cGVHD) that will receive immediate funding through the Innovative Medicines Fund (IMF) Sanofi
03-Jan-2024 Calibre Scientific Acquires LineaLAB Calibre Scientific
03-Jan-2024 Longest strike in NHS history leaves local services ‘skating on the thinnest of ice’, warn NHS leaders NHS Confederation
03-Jan-2024 Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year AccessWire
03-Jan-2024 Glidewell to Host Seven Symposia in 2024 AccessWire
03-Jan-2024 Carebox and Gastric Cancer Foundation (GCF) Announce the GCF Clinical Trial Finder AccessWire
03-Jan-2024 Introducing PillSafe®, the New ‘Smart’ Pill Bottle for Prescription Medication Newswire
03-Jan-2024 OneMedNet iRWD(TM) Now Available on AWS Data Exchange AccessWire
03-Jan-2024 Introducing PillSafe(R), the New 'Smart' Pill Bottle for Prescription Medication AccessWire
03-Jan-2024 Pen Needles Market is estimated to be US$ 4.5 Billion by 2032 and is anticipated to register a CAGR of 10.3% – By Allied The Wire Times
03-Jan-2024 Protagonist Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference AccessWire